Envista Reports Third Quarter 2026 Results
Envista Holdings Corp (NVST) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Envista Reports Third Quarter 2026 Results BREA, Calif., November 4, 2026 / PRNewswire / -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended October 2, 2026. “Envista delivered another quarter of profitable growth, gaining share
How this was made
The 30-second read
Why it matters
The revised guidance raises expectations for full‑year sales and EBITDA, which could attract buying interest.
Market read
The earnings beat and guidance update provide a fresh catalyst for NVST, potentially influencing related healthcare equipment stocks.
What to watch
Foreign currency translation gain boosted earnings but has no cash impact; analysts may focus on cash flow sustainability.
Envista Reports Third Quarter 2026 Results
Third-quarter core sales growth was 2.7%, adjusted diluted EPS was $0.40 (+25% year-over-year), adjusted EBITDA was $106 million (+9% year-over-year), and the company raised its full-year adjusted diluted EPS guidance.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| Sales, three months ended October 2, 2026GAAP | $691.5M | – | 3.2 % |
| Core Sales Growth, three months ended October 2, 2026non-GAAP | 2.7 % | – | 2.7 % |
| Gross Profit, three months ended October 2, 2026GAAP | $400.6M | – | – |
| Gross Margin, three months ended October 2, 2026GAAP | 57.9 % | – | – |
| Adjusted Gross Profit, three months ended October 2, 2026non-GAAP | $389.5M | – | – |
| Adjusted Gross Margin, three months ended October 2, 2026non-GAAP | 56.3 % | – | +20 bps year-over-year |
| Selling, general and administrative expenses, three months ended October 2, 2026GAAP | $284.2M | – | – |
| Research and development expenses, three months ended October 2, 2026GAAP | $29.3M | – | – |
| Realized cumulative foreign currency translation gain, three months ended October 2, 2026GAAP | −$428.1M | – | – |
| Operating Profit, three months ended October 2, 2026GAAP | $515.2M | – | – |
| Adjusted Operating Profit, three months ended October 2, 2026non-GAAP | $95M | – | – |
| Adjusted Operating Profit as a % of Sales, three months ended October 2, 2026non-GAAP | 13.7 % | – | – |
| Net Income, three months ended October 2, 2026GAAP | $508.3M | – | – |
| Adjusted Net Income, three months ended October 2, 2026non-GAAP | $65.2M | – | – |
| Diluted Earnings Per Share, three months ended October 2, 2026GAAP | $ 3.11 | – | – |
| Adjusted Diluted EPS, three months ended October 2, 2026non-GAAP | $ 0.40 | – | +25% year-over-year |
| Adjusted EBITDA, three months ended October 2, 2026non-GAAP | $105.8M | – | +9% year-over-year |
| Adjusted EBITDA as a % of Sales, three months ended October 2, 2026non-GAAP | 15.3 % | – | +80 bps year-over-year |
| Operating Cash Flow, three months ended October 2, 2026GAAP | $77.9M | – | – |
| Free Cash Flow, three months ended October 2, 2026non-GAAP | $63.5M | – | – |
| FCF to Adjusted Net Income Conversion Ratio, three months ended October 2, 2026non-GAAP | 97.4 % | – | – |
| Sales, nine months ended October 2, 2026GAAP | $2.13B | – | 8.1 % |
| Core Sales Growth, nine months ended October 2, 2026non-GAAP | 5.6 % | – | 5.6 % |
| Gross Profit, nine months ended October 2, 2026GAAP | $1.20B | – | – |
| Gross Margin, nine months ended October 2, 2026GAAP | 56.3 % | – | – |
| Adjusted Gross Profit, nine months ended October 2, 2026non-GAAP | $1.19B | – | – |
| Adjusted Gross Margin, nine months ended October 2, 2026non-GAAP | 55.7 % | – | – |
| Operating Profit, nine months ended October 2, 2026GAAP | $658M | – | – |
| Adjusted Operating Profit, nine months ended October 2, 2026non-GAAP | $278.9M | – | – |
| Net Income, nine months ended October 2, 2026GAAP | $600.7M | – | – |
| Adjusted Net Income, nine months ended October 2, 2026non-GAAP | $191.7M | – | – |
| Diluted Earnings Per Share, nine months ended October 2, 2026GAAP | $ 3.65 | – | – |
| Adjusted Diluted EPS, nine months ended October 2, 2026non-GAAP | $ 1.16 | – | – |
| Adjusted EBITDA, nine months ended October 2, 2026non-GAAP | $312.4M | – | – |
| Operating Cash Flow, nine months ended October 2, 2026GAAP | $193.8M | – | – |
| Free Cash Flow, nine months ended October 2, 2026non-GAAP | $152.9M | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Specialty Products & Technologies, three months ended October 2, 2026Total sales growth was 2.8 %; acquisitions had a (0.8) % impact and currency exchange rates had a — % impact. | $443.7M | – | 2.0 % core sales growth |
| Equipment & Consumables, three months ended October 2, 2026Total sales growth was 3.9 %; currency exchange rates had a 0.2 % impact. | $247.8M | – | 4.1 % core sales growth |
| Specialty Products & Technologies, nine months ended October 2, 2026Total sales growth was 7.5 %; acquisitions had a (0.8) % impact and currency exchange rates had a (2.3) % impact. | $1.37B | – | 4.4 % core sales growth |
| Equipment & Consumables, nine months ended October 2, 2026Total sales growth was 9.1 %; currency exchange rates had a (1.2) % impact. | $755M | – | 7.9 % core sales growth |
Full year 2026 outlook
- NoteCore Sales Growth: 3.75% to 4.25%
- NoteAdjusted EBITDA Growth: 12.5% to 14%
- NoteAdjusted Diluted Earnings Per Share: $1.54 to $1.58
- NoteFree Cash Flow Conversion: ~100%
Capital returns
- During the quarter ended October 2, 2026, Envista repurchased 386 thousand shares for approximately $10 million.
- At the end of the quarter, Envista had approximately $273 million of remaining repurchase capacity under its stock repurchase program.
- Cash paid for treasury stock under the stock repurchase program was $ 113.0 million for the nine months ended October 2, 2026, compared with $ 142.3 million for the nine months ended September 26, 2025.
What drove it
- Both reporting segments delivered positive core sales growth: 2.0% in Specialty Products & Technologies and 4.1% in Equipment & Consumables.
- Ongoing contributions from the Envista Business System contributed to year-over-year adjusted gross margin expansion of 20 bps.
- The U.S. Supreme Court's ruling to refund tariffs imposed under the International Emergency Economic Powers Act was reflected as tariff refunds of $ (15.6) million in third-quarter adjusted gross profit and adjusted operating profit reconciliations.
- The company raised full-year 2026 adjusted EBITDA growth guidance to 12.5% to 14% from 11% to 14%, and adjusted diluted EPS guidance to $1.54 to $1.58 from $1.50 to $1.55.
Concerns
- GAAP results included a realized cumulative foreign currency translation gain of $428 million in operating profit and $2.62 of diluted EPS before associated tax effects; the company stated the gain had no cash impact and no impact on adjusted EBITDA, adjusted operating income, or adjusted diluted EPS.
- Third-quarter free cash flow was $ 63.5 million, compared with $ 67.9 million in the prior-year quarter.
- The release states that actual results may be affected by conditions in the U.S. and global economy, inflation, interest rates, trade policies and regulations including tariffs, currency exchange rates, supply-chain disruptions, debt obligations, and other listed factors.
What to watch
- Delivery against full-year core sales growth guidance of 3.75% to 4.25%.
- Delivery against full-year adjusted EBITDA growth guidance of 12.5% to 14%.
- Delivery against full-year adjusted diluted EPS guidance of $1.54 to $1.58.
- Free cash flow conversion relative to the full-year guidance of ~100%.
- The ongoing effect of tariff refunds and the exclusion of the realized cumulative foreign currency translation gain from adjusted results.
Balance sheet and cash flow
- Cash and cash equivalents were $ 1,158.8 million as of October 2, 2026, compared with $ 1,211.7 million as of December 31, 2025.
- Long-term debt was $ 1,429.0 million as of October 2, 2026, compared with $ 1,448.3 million as of December 31, 2025.
- Net cash provided by operating activities was $ 193.8 million for the nine months ended October 2, 2026, compared with $ 167.7 million for the nine months ended September 26, 2025.
- Payments for additions to property, plant and equipment were $ 43.5 million for the nine months ended October 2, 2026, compared with $ 29.0 million for the nine months ended September 26, 2025.
- Acquisitions, net of cash acquired were $ 54.3 million for the nine months ended October 2, 2026.
Analysis
Envista reported third-quarter sales of $ 691.5 million, compared with $ 669.9 million in the prior-year quarter. Total sales growth was 3.2 %, while core sales growth was 2.7 %. Both reporting segments posted positive core sales growth, led by Equipment & Consumables at 4.1 %, while Specialty Products & Technologies delivered 2.0 %. For the first nine months, sales were $ 2,127.5 million and core sales growth was 5.6 %.
Profitability improved on an adjusted basis. Adjusted gross margin was 56.3 % compared with 56.1 %, and management cited a 20 bps year-over-year expansion. Adjusted operating profit was $ 95.0 million compared with $ 85.6 million, adjusted EBITDA was $ 105.8 million compared with $ 97.1 million, and adjusted EBITDA margin expanded to 15.3 % from 14.5 %. Adjusted diluted EPS was $ 0.40 compared with $ 0.32.
GAAP earnings were materially affected by a realized cumulative foreign currency translation gain. The company recognized a gain resulting in $428 million in operating profit and $2.62 of diluted EPS before associated tax effects. Consequently, GAAP operating profit was $ 515.2 million, net income was $ 508.3 million, and diluted EPS was $ 3.11. Envista stated that this gain had no cash impact and no impact on adjusted EBITDA, adjusted operating income, or adjusted diluted EPS.
Cash generation was lower in the quarter, with operating cash flow of $ 77.9 million compared with $ 78.7 million and free cash flow of $ 63.5 million compared with $ 67.9 million. For the nine-month period, operating cash flow was $ 193.8 million and free cash flow was $ 152.9 million. The company repurchased 386 thousand shares for approximately $10 million during the quarter and ended with approximately $273 million of remaining repurchase capacity.
Management updated full-year 2026 guidance. Core sales growth is now expected at 3.75% to 4.25%, adjusted EBITDA growth at 12.5% to 14%, and adjusted diluted EPS at $1.54 to $1.58. Free cash flow conversion guidance remained ~100%. The increased adjusted EBITDA growth and adjusted diluted EPS ranges place attention on whether the reported margin progress, segment-level core growth, and cash conversion continue through the balance of 2026.
Management, verbatim
Envista delivered another quarter of profitable growth, gaining share and expanding margins.
Paul Keel, CEO
Supported by the Envista Business System, we are converting broad-based topline performance into even stronger earnings growth, while continuing to invest in our customers, colleagues and communities to sustain long-term success.
Paul Keel, CEO
Our strong momentum and year-to-date progress give us confidence to raise our full-year earnings guidance once again.
Paul Keel, CEO
Not in the filing
stated, not guessed- Previous-release outlook section was not provided; therefore, no comparison of actual results versus prior guidance is included.
- GAAP tax rate and adjusted tax rate were not reported.
- Quarterly debt maturities, interest rate, net debt, and liquidity availability were not reported.
- Dividend amount, dividend declaration, and dividend payment date were not reported.
- Prior-quarter values for the reported metrics were not reported.
Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
Envista Holdings Corp (NYSE:NVST) released its third‑quarter 2026 earnings via an SEC Form 8‑K, highlighting profit growth and an updated outlook.
Ticker impact
Envista reported Q3 2026 results with higher sales, EPS and updated full‑year guidance.
likely upward pressure as investors price in the revised guidance
The company issued revised guidance with higher core sales and EBITDA growth ranges, indicating improved performance.
Market effects
Dental equipment sector may see modest uplift as a leading player signals stronger demand.
U.S. investors may adjust exposure to healthcare equipment stocks.
Limited to markets tracking dental and medical device manufacturers.
Counterpoint
If the guidance upgrade is already priced in, the stock could face short‑term profit taking.
Key entities
- companyEnvista Holdings Corp
Dental equipment and consumables manufacturer.
